reference/16647217

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16647217

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	367
issn	1465-6566 1744-7666
issueIdentifier	3
pageRange	359-367
publicationName	Expert Opinion on Pharmacotherapy
startingPage	359
bibliographicCitation	Ringleb PA, Schwark C, Schwaninger M, Schellinger PD. Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke. Expert Opin Pharmacother. 2005 Mar;6(3):359–67. doi: 10.1517/14656566.6.3.359. PMID: 15794727.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e424abdfc40575c3ed7f97823865567f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac99fb62ce783080f12ed6035bf76c3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_257ba0f5a6ef5380f600db4d04ce9178 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb37eef23f90bfe263e7fb8d78998a51
date	200503
identifier	https://pubmed.ncbi.nlm.nih.gov/15794727 https://doi.org/10.1517/14656566.6.3.359
isPartOf	https://portal.issn.org/resource/ISSN/1744-7666 https://portal.issn.org/resource/ISSN/1465-6566 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22235
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke
discusses	http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0006533
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002545Q000517 http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D010975Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003362 http://id.nlm.nih.gov/mesh/D004176Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013988Q000627 http://id.nlm.nih.gov/mesh/D000077144 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D013988Q000031 http://id.nlm.nih.gov/mesh/D020521Q000191 http://id.nlm.nih.gov/mesh/D017048
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7218 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11310 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7442 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6746

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128241576 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127968075 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128918298

Total number of triples: 55.